PAPA Medical Inc.
PAPA
NASDAQ
Recommendation
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 56.87% | 51.72% | 40.94% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 56.87% | 51.72% | 40.94% | -- | -- |
| Cost of Revenue | 59.50% | 56.05% | 43.06% | -- | -- |
| Gross Profit | 49.13% | 39.51% | 34.97% | -- | -- |
| SG&A Expenses | 64.32% | 71.34% | 85.74% | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 60.99% | 59.40% | 51.04% | -- | -- |
| Operating Income | -5.67% | -36.73% | -56.01% | -- | -- |
| Income Before Tax | -8.84% | -43.47% | -63.90% | -- | -- |
| Income Tax Expenses | -35.70% | -85.68% | -90.38% | -- | -- |
| Earnings from Continuing Operations | 2.25% | -23.06% | -52.36% | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.25% | -23.06% | -52.36% | -- | -- |
| EBIT | -5.67% | -36.73% | -56.01% | -- | -- |
| EBITDA | 24.92% | -16.59% | -38.53% | -- | -- |
| EPS Basic | 2.27% | -22.99% | -52.38% | -- | -- |
| Normalized Basic EPS | -5.52% | -35.53% | -56.72% | -- | -- |
| EPS Diluted | 2.27% | -22.99% | -52.38% | -- | -- |
| Normalized Diluted EPS | -5.52% | -35.53% | -56.72% | -- | -- |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | -- | -- |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |